1. Cross, G. A. 1990. Cellular and genetic aspects of antigenic variation in trypanosomes. Annu. Rev. Immunol.8:83-110.
2. Dempsey, W. L., and J. M. Mansfield. 1983. Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity. J. Immunol.130:405-411.
3. Freire-de-Lima, C. G., M. P. Nunes, S. Corte-Real, M. P. Soares, J. O. Previato, L. Mendonca-Previato, and G. A. DosReis. 1998. Proapoptotic activity of a Trypanosoma cruzi ceramide-containing glycolipid turned on in host macrophages by IFN-gamma. J. Immunol.161:4909-4916.
4. Fukuda, R., N. Ishimura, T. X. Nguyen, A. Chowdhury, S. Ishihara, N. Kohge, S. Akagi, M. Watanabe, and S. Fukumoto. 1995. The expression of IL-2, IL-4 and interferon-gamma (IFN-gamma) mRNA using liver biopsies at different phases of acute exacerbation of chronic hepatitis B. Clin. Exp. Immunol.100:446-451.
5. Galle, P. R., W. J. Hofmann, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P. H. Krammer, and L. Runkel. 1995. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med.182:1223-1230.